An interventional study of Cannulation with AccuVein AV400 in Liver Cirrhosis, sponsored by University Hospital, Caen. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-08-24.
Sponsored by University Hospital, Caen · Not applicable, Interventional, and Supportive care
The objective of this study is to evaluate the effectiveness of AccuVein AV400 to facilitate placement of peripheral intravenous catheters in cirrhotic adults by comparing the success rate of the first attempt to install a peripheral venous catheter with or without AccuVein AV400®.
1,642 studies on the registry are indexed under Liver Cirrhosis; 358 are open to participants now.
This study's planned enrollment of 280 is above the median of 72 across 995 interventional studies indexed under Liver Cirrhosis.
Browse Liver Cirrhosis studies →University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Cirrhotic patients benefit from the support of a venous illumination device for each peripheral venous cannulation
Device: Cannulation with AccuVein AV400
Cirrhotic patients benefit from the standard technique of peripheral veinous catheter placement.
Cannulation using AccuVein AV400 device
Also known as: AccuVein AV400
First Attempt Success Rate of Cannulation
Firt attempt success of positional for each peripheral venous catheter and expressed as a percentage in cirrhotic patients during hospitalization.
Time frame: baseline
change of the score A-DIVA
Scores A-DIVA between beginning and end of hospitalization between the two groups
Time frame: baseline and end of hospitalization (up to a month)
Cost
Cost of consumables used in euro between the two groups
Time frame: baseline
Life expectancy of the catheter
Life expectancy of the catheter between the two groups
Time frame: baseline
Utilisation of a central venous catheter
Use of a central venous catheter (y/n)
Time frame: baseline
Pain's score
visual analogic scale
Time frame: baseline
Numbers of attempts
Number of attempts between two groups
Time frame: baseline
This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Caen